Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Lack of Research Reproducibility Calls Scientific Integrity Into Question

XTALKS VITALS NEWS

Research

The journal, Nature conducted a survey last year which found that over 70 percent of researchers have, at one time or another, been unable to reproduce another’s results by conducting the same experiments.

Share this!

February 27, 2017 | by Sarah Hand, M.Sc.

The University of Virginia's Centre for Open Science hosts The Reproducibility Project, a group of scientists with the aim of replicating the results reported in five large cancer studies. The researchers have been working on the project since 2011, however they have only been able to reproduce the results of two of the original studies.

“The idea here is to take a bunch of experiments and to try and do the exact same thing to see if we can get the same results,” Dr. Tim Errington, head of The Reproducibility Project, told BBC News. Since scientific papers contain detailed Material and Methods sections outlining the details of the original experiments, one would assume that following this recipe should produce similar results.

Unfortunately, Errington’s findings suggests a growing problem in the life science industry where irreproducible research may be misguiding further studies. “It's worrying because replication is supposed to be a hallmark of scientific integrity,” said Errington.

The journal, Nature conducted a survey last year which found that over 70 percent of researchers have, at one time or another, been unable to reproduce another’s results by conducting the same experiments. Most scientists believe that the problem isn’t a matter of the study authors presenting fraudulent data, but instead lies within the publishing process itself.

“What we see in the published literature is a highly curated version of what's actually happened,” said Dr. Marcus Munafo, professor of biological psychology at Bristol University. “The trouble is that gives you a rose-tinted view of the evidence because the results that get published tend to be the most interesting, the most exciting, novel, eye-catching, unexpected results.”



There are many factors that contribute to this growing issue: funding bodies that want to see big returns on their investment, peer reviewed journals interested in publishing only the most exciting results, and research institutions that rely on major research projects to secure financial backing. “Everyone has to take a share of the blame,” said Dame Ottoline Leyser, director of the Sainsbury Laboratory at the University of Cambridge. “The way the system is set up encourages less than optimal outcomes.”

So how can we solve this problem? According to Nature, getting researchers to think about the reproducibility of their work could be the first step to addressing this issue. The prestigious journal has created a reproducibility checklist designed to encourage researchers to improve their study’s rigour before submitting their paper for publication.

“Replication is something scientists should be thinking about before they write the paper,” said Ritu Dhand, the editorial director at Nature. “It's going to take a multi-pronged approach involving funders, the institutes, the journals and the researchers.”


Keywords: Research Reproducibility, Scientific Integrity, Publication


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Better Meal Planning for Diabetics Using a Predictive Blood Sugar App

April 21, 2017 - A new app could allow people with type 2 diabetes to make predictions about the impact of a meal on their blood sugar levels, before they even take a bite.

Featured In: Life Science News


Bacterial Biomarkers Could Make Diagnosing Colorectal Cancer Less Invasive

April 20, 2017 - Researchers at The University of Texas Health Science Center at Houston School of Public Health have identified specific strains of gut bacteria which have been associated with colorectal cancer.

Featured In: Life Science News


Weetabix Cereal Sold to Post in £1.4 Billion Deal

April 20, 2017 - The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Featured In: Food News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

Electronic Informed Consent: 2017 Industry Survey Results


Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-Time


The Modernization of eCOA Technology for Clinical Trials


Developing a Biological Safety Evaluation


Copyright © 2016-2017 Honeycomb Worldwide Inc.